PMC:7164862 / 2481-2830
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 81 | 78-86 | Species | denotes | SARS-CoV | Tax:694009 |
| 82 | 203-209 | Species | denotes | humans | Tax:9606 |
| 87 | 52-63 | Chemical | denotes | chloroquine | MESH:D002738 |
| 99 | 247-254 | Disease | denotes | malaria | MESH:D008288 |
| 103 | 107-109 | CellLine | denotes | E6 | CVCL:4582 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T2 | 110-115 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
| T3 | 161-167 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T25 | 78-86 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T26 | 247-254 | Disease | denotes | malaria | http://purl.obolibrary.org/obo/MONDO_0005136 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T11 | 102-115 | http://purl.obolibrary.org/obo/CLO_0051719 | denotes | Vero E6 cells |
| T12 | 161-167 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T13 | 203-209 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | humans |
| T14 | 258-259 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T19 | 52-63 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T20 | 219-223 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T9 | 0-349 | Sentence | denotes | The half-maximal inhibitory concentration (IC50) of chloroquine inhibition of SARS-CoV replication in Vero E6 cells, 8·8 μmol/L, is substantially lower than the plasma concentrations that are reached in humans when the drug is prescribed to treat malaria at a dose of 25 mg/kg over 3 days.1 For long-term prophylaxis, even lower doses could be used. |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T50 | 52-63 | CHEBI:3638;DG_10;CHEBI:3638 | denotes | chloroquine |
| T51 | 78-86 | SP_10 | denotes | SARS-CoV |
| T52 | 87-98 | GO:0006260 | denotes | replication |
| T53 | 102-106 | CL_6 | denotes | Vero |
| T54 | 161-167 | UBERON:0001969 | denotes | plasma |
| T55 | 203-209 | NCBITaxon:9606 | denotes | humans |
| T56 | 219-223 | CHEBI:23888;CHEBI:23888 | denotes | drug |
| T10976 | 52-63 | CHEBI:3638;DG_10;CHEBI:3638 | denotes | chloroquine |
| T85528 | 78-86 | SP_10 | denotes | SARS-CoV |
| T53974 | 87-98 | GO:0006260 | denotes | replication |
| T6318 | 102-106 | CL_6 | denotes | Vero |
| T36294 | 161-167 | UBERON:0001969 | denotes | plasma |
| T60655 | 203-209 | NCBITaxon:9606 | denotes | humans |
| T6054 | 219-223 | CHEBI:23888;CHEBI:23888 | denotes | drug |